Blood Test for NT-proBNP Predicts Cardiac Events and Death in Heart Patients
Filed in archive Diagnostics, Methodologies and Instrumentation on January 16, 2007
Scientists have developed a blood test for detecting the protein NT-proBNP, which can predict the risk of heart attack, heart failure, stroke, and death in patients with known cardiovascular disease.
NT-proBNP is a marker in the blood for BNP, a hormone that "goes up during times of cardiac stretch or stress," explains Whooley. "When the heart wall is over-expanded by too much blood volume, or damaged by lack of blood flow to the heart itself, BNP goes up, and NT-proBNP along with it."
In a study involving 987 patients with history of cardiovascular disease, those with the highest levels of the biomarker were found to be 3.4 times more likely to die or have a cardiovascular event than patients in the group with the lowest levels.
Read more form the UCSF report, or the study as published in the January 10, 2007 issue of Journal of the american medical association.

Tags: heart+attack cardiovascular+disease blood+test diagnostics biomarkers biotech death+heart heart+pati
Vote for Blood Test for NT-proBNP Predicts Cardiac Events and Death in Heart Patients:
|
Rating: 6.20 out of 5 vote(s) cast.
|
Response from:
Trusted.MD Network
What happens before a heart attack (myocardial infarction)?
© gandhiji40
Most Popular
Best of
Biotech Hubs and Facilities
Biotech/Science Blogs
Corporate and Industrial News
Diagnostics, Methodologies and Instrumentation
Did you know
Drugs, Vaccines and Therapeutics
Energy, Environment and Ecology
Food and Agriculture
Gene Therapy
Genomics, Proteomics and Bioinformatics
Information About
Meetings and Other Events
Microbiology
Misc
Nanomedicine
Other Biotechnology News
Patents and Intellectual Property Rights
Quick introduction
Stem Cells
